logo
‘What can we do with this, other than watch it multiply?': Expert warns over lab-grown bat viruses as 20 new strains discovered

‘What can we do with this, other than watch it multiply?': Expert warns over lab-grown bat viruses as 20 new strains discovered

Sky News AU5 days ago

Scientists are sounding the alarm after 20 new viruses were discovered in fruit bats in southern China - including two that are genetically similar to the deadly Hendra and Nipah viruses.
The findings, published in the journal PLOS Pathogens, have prompted fresh warnings over future spillover threats to humans and livestock - but not all the concern is about the viruses themselves.
Australian infectious diseases expert Professor Peter Collignon has raised concerns over the way such viruses are being studied, warning that lab-based research may give dangerous pathogens a 'head start'.
'It's a concern that these viruses are often grown in laboratories in human or monkey cell types, and you have to ask yourself - what can we do with this other than watch it multiply?' Professor Collignon told SkyNews.com.au.
The viruses were uncovered after researchers examined the kidneys of 142 fruit bats from the Yunnan province, a biodiversity hotspot bordering Myanmar and Laos.
Unlike most studies that analyse bat droppings, this research focused on organ tissues - uncovering a trove of previously unknown viruses and revealing a rarely studied viral reservoir.
Two of the viruses, dubbed Yunnan bat Henipavirus 1 and 2, are particularly concerning due to their genetic similarities to Hendra and Nipah - pathogens known for causing fatal outbreaks in humans and animals, with fatality rates as high as 80 per cent.
The viruses, which can spread via bat urine, were found in animals roosting near orchards and villages - raising concerns about possible transmission to livestock or people via contaminated fruit or surfaces.
The Hendra virus, first detected in Brisbane in 1994, has caused the deaths of four people and dozens of horses in Australia.
With flying fox populations increasingly seen in peri-urban and agricultural areas, the environmental conditions in Yunnan are drawing direct comparisons to those in parts of Australia.
But as more of these viruses are found, debate is growing over whether the act of studying them - particularly in labs - could pose its own risks.
'With what's happening at the moment by growing these viruses in a lab in human cell lines, it's only giving the virus a head start in an ability to infect people rather than just bats,' Mr Collignon said.
'We get information about it, which is obviously important, but there's usually no other benefit - except maybe the people carrying out the study getting extra grants.'
He said the value of identifying these viruses is often overstated, arguing that knowing about Covid-19 in bats before the pandemic made little difference to prevention.
'We knew about coronaviruses including those from bats, long before the pandemic happened, but really, how does that help? It didn't really,' he said.
'We likely only know about one per cent of the viruses out there. Knowing about them doesn't always mean we can stop them.'
Mr Collignon also questioned public messaging which linked bat virus studies to current vaccine campaigns, calling it misplaced and potentially misleading.
'Like coming out now and trying to prevent this virus harming people by telling people to get the current Covid vaccine. It just won't help, as it's very unlikely we will get cross protection' he said.
'It's misleading information.'
Ecologists, meanwhile, say the real issue is habitat destruction - not laboratory research.
Deforestation, habitat fragmentation, and food shortages are forcing bats to forage closer to human environments, which has been linked to increased risk of zoonotic spillover in both Asia and Australia.
A 2023 study of Hendra outbreaks in horses found a strong link between bat food scarcity and virus transmission.
As natural food sources decline, bats have been increasingly observed feeding in orchards and farms, heightening the risk of contact.
Many ecologists argue conservation - not culling - is key to reducing the risk of disease emergence.
Maintaining native food sources and restoring natural habitats can help bats stay away from farmland, they say, reducing spillover risk at the source.
While there's no evidence the newly discovered viruses have yet infected humans, the discovery highlights how little is still known about the microbial world carried by wildlife - especially in biodiversity hotspots.
Mr Collignon stressed the importance of balancing research with caution.
'There's always going to be that natural concern between bats, the viruses they carry and the risk to the public,' he said.
'But giving [a virus] a head start as part of research program that grows these viruses in human cell lines is not good.'
Experts are calling for a more ecological approach to disease prevention - one that treats habitat protection as frontline public health.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Non-binary Australian suicide contemplation rates soar, Kat Elsby shares experience
Non-binary Australian suicide contemplation rates soar, Kat Elsby shares experience

Herald Sun

time4 hours ago

  • Herald Sun

Non-binary Australian suicide contemplation rates soar, Kat Elsby shares experience

Don't miss out on the headlines from Mental Health. Followed categories will be added to My News. Growing up, Kat Elsby always felt like there was something missing. Assigned female at birth, Kat felt like an 'alien dropped off on the wrong planet' most of their life. 'I felt like an alien that just looked like everyone else but didn't feel like them,' Kat, who is a non-binary trans person, said. 'I just didn't understand people talking about feeling like a girl or a woman. 'None of this stuff made sense to me.' This feeling took a heavy toll on Kat's mental health, including suicidal thoughts and attempts. It wasn't until Kat was 23 that they learnt about gender diverse terms and everything clicked. 'It was like a light bulb going off in my head and a huge part of myself suddenly made sense,' Kat, now 38, said. 'I've known these things about myself my whole life, I just didn't have the words to describe them. 'But it was also that knowledge of if there's other people out there like me, I'll be able to find them.' Despite growing awareness of mental health issues, suicide remains a critical concern for the nation's LGBTQ+ community. Non-binary people are among the most vulnerable, experiencing mental health issues at more than double the rate of cisgender people. According to the Australian Institute of Health and Welfare, 79 per cent of non-binary people have experienced suicidal thoughts compared to 14 per cent of men and 18 per cent of women. 'It's the norm to think maybe the world would be better off if I wasn't here and that is absolutely heartbreaking,' Kat said. 'We lose so many people because it's not just that people struggle with these thoughts, it's that they act on them.' The Adelaide local, who trains suicide prevention workers at prevention organisation Roses in the Ocean, said peer support from LGBTQ+ people with lived experience went a long way. Through the organisation's Peer CARE Companion Warmline, people can connect with someone 'who shares aspects of their identity'. 'It makes a real difference when people can connect with someone who's walked a similar path.' Proper training in LGBTQ+ services and correct pronoun use is crucial for inclusive healthcare. 'Some services still don't get the basics right,' Kat said. 'People often have to educate services about their gender identity or sexuality just to get support.' For those struggling with their mental health, it's never too late to reach out. 'There are people out there that will understand you and they will accept you,' Kat said. 'It can feel very lonely but there are fantastic spaces out there like Shine SA, Thorne Harbour Health, Headspace and Safe Haven.' If you or a loved one needs support, call Lifeline on 13 11 41 Originally published as Kat Elsby uses lived experience to train non-binary suicide prevention workers as Australian contemplation rates soar

Milestone first patent for Proteomics simple endometriosis test
Milestone first patent for Proteomics simple endometriosis test

The Age

time6 hours ago

  • The Age

Milestone first patent for Proteomics simple endometriosis test

In a milestone moment, ASX-listed diagnostics innovator Proteomics International Laboratories has achieved its first patent globally in Japan for its simple 'traffic light' diagnostic blood test for endometriosis. The decision will protect the company's intellectual property rights for its PromarkerEndo technology in the world's fourth-largest healthcare market until March 16, 2041. Proteomics says Japan's healthcare sector already widely uses in vitro diagnostics and precision medicine technologies to customise treatments for patients and help deliver better patient outcomes. The company is planning to start an international commercial roll-out of the device within months using its existing direct-to-consumer channels, while also tapping into general practitioners and women's health specialists. 'This is a significant achievement because it validates the novelty of PromarkerEndo, our world-first blood test for endometriosis.' Proteomics International managing director Dr Richard Lipscombe Proteomics International managing director Dr Richard Lipscombe said: 'Securing patent protection for our diagnostic technology in this region is a key step in our global commercialisation pathway and provides a strong foundation for potential partnerships, licensing, and regulatory advancement.' PromarkerEndo promises to revolutionise women's reproductive healthcare by delivering the first clinically viable, real-world, non-invasive diagnostic test for a disease affecting one in nine women and girls. Estimates suggest endometriosis costs the Australian economy nearly $10 billion annually. Its symptoms can be devastating for women, but it has historically been difficult to diagnose. It can take up to seven years on average for women to be diagnosed with endometriosis, using painful and invasive laparoscopy and tissue biopsies, performed under anaesthetics. For the first time, doctors may instead be able to turn to PromarkerEndo as a frontline tool in detecting endometriosis in symptomatic patients. The device uses a universal 'traffic light' risk score - low, moderate or high - to indicate a patient's likelihood of having the disease.

Milestone first patent for Proteomics simple endometriosis test
Milestone first patent for Proteomics simple endometriosis test

Sydney Morning Herald

time6 hours ago

  • Sydney Morning Herald

Milestone first patent for Proteomics simple endometriosis test

In a milestone moment, ASX-listed diagnostics innovator Proteomics International Laboratories has achieved its first patent globally in Japan for its simple 'traffic light' diagnostic blood test for endometriosis. The decision will protect the company's intellectual property rights for its PromarkerEndo technology in the world's fourth-largest healthcare market until March 16, 2041. Proteomics says Japan's healthcare sector already widely uses in vitro diagnostics and precision medicine technologies to customise treatments for patients and help deliver better patient outcomes. The company is planning to start an international commercial roll-out of the device within months using its existing direct-to-consumer channels, while also tapping into general practitioners and women's health specialists. 'This is a significant achievement because it validates the novelty of PromarkerEndo, our world-first blood test for endometriosis.' Proteomics International managing director Dr Richard Lipscombe Proteomics International managing director Dr Richard Lipscombe said: 'Securing patent protection for our diagnostic technology in this region is a key step in our global commercialisation pathway and provides a strong foundation for potential partnerships, licensing, and regulatory advancement.' PromarkerEndo promises to revolutionise women's reproductive healthcare by delivering the first clinically viable, real-world, non-invasive diagnostic test for a disease affecting one in nine women and girls. Estimates suggest endometriosis costs the Australian economy nearly $10 billion annually. Its symptoms can be devastating for women, but it has historically been difficult to diagnose. It can take up to seven years on average for women to be diagnosed with endometriosis, using painful and invasive laparoscopy and tissue biopsies, performed under anaesthetics. For the first time, doctors may instead be able to turn to PromarkerEndo as a frontline tool in detecting endometriosis in symptomatic patients. The device uses a universal 'traffic light' risk score - low, moderate or high - to indicate a patient's likelihood of having the disease.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store